Astera Labs, Inc. Common Stock (ALAB)
USD 55.68
(-13.11%)
USD 55.68
(-13.11%)
| Breakdown | 2023 | 2022 |
|---|---|---|
| Operating Cash Flow | -12.71 Million | -35.89 Million |
| Net Income | -26.25 Million | -58.34 Million |
| Depreciation & Amortization | 1.78 Million | 807 Thousand |
| Deferred income taxes | - | - |
| Stock-based compensation | 10.67 Million | 30.23 Million |
| Change in working capital | -9.67 Million | -9.97 Million |
| Other non-cash items | 10.75 Million | 56.49 Million |
| Investing Cash Flow | -17.77 Million | -90.59 Million |
| Investments in PPE | -2.76 Million | -3.87 Million |
| Acquisitions | - | - |
| Investment purchases | -126.22 Million | -88.71 Million |
| Sales/Maturities of investments | 111.21 Million | 1.99 Million |
| Other Investing Activities | -15.01 Million | -86.71 Million |
| Financing Cash Flow | -502 Thousand | 151.66 Million |
| Debt repayment | - | - |
| Dividends payments | - | - |
| Common Stock Repurchased | -210 Thousand | -313 Thousand |
| Common Stock Issuance | -292 Thousand | 151.98 Million |
| Other Financing Activities | -292 Thousand | 151.98 Million |
| Accounts receivables | 2.38 Million | -6.03 Million |
| Accounts payables | -4.26 Million | 2.12 Million |
| Inventory | -5.56 Million | -19.35 Million |
| Other working capital | -2.23 Million | 13.29 Million |
| Cash at beginning of period | 76.08 Million | 50.9 Million |
| Cash at end of period | 45.09 Million | 76.08 Million |
| Capital Expenditure | -2.76 Million | -3.87 Million |
| Effect of forex changes on cash | - | - |
| Net cash flow / Change in cash | -30.99 Million | 25.18 Million |
| Free Cash Flow | -15.47 Million | -39.77 Million |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -7.59 Million | -7.54 Million | -92.99 Million | -26.25 Million | -3.12 Million | -20 Million |
| Depreciation & Amortization | 849 Thousand | 700 Thousand | 614 Thousand | 1.78 Million | - | 406 Thousand |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | 43.06 Million | 97.76 Million | 10.67 Million | 2.71 Million | 2.67 Million |
| Change in working capital | 27.4 Million | -7.33 Million | -2.22 Million | -9.67 Million | - | -6.19 Million |
| Other non-cash items | 42.84 Million | 928 Thousand | 108.83 Million | 32.43 Million | 413 Thousand | 319 Thousand |
| Investing Cash Flow | -359.41 Million | -302.47 Million | -4.25 Million | -17.77 Million | - | 9.16 Million |
| Investments in PPE | -16.69 Million | 1.32 Million | -3.42 Million | -2.76 Million | - | -575 Thousand |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | -379.16 Million | -322.44 Million | -23.3 Million | -126.22 Million | - | -4.92 Million |
| Sales/Maturities of investments | 36.44 Million | 18.65 Million | 22.48 Million | 111.21 Million | - | 14.66 Million |
| Other Investing Activities | - | - | -827 Thousand | -15.01 Million | - | 9.73 Million |
| Financing Cash Flow | 952 Thousand | -2.34 Million | 651.57 Million | -502 Thousand | - | -118 Thousand |
| Debt repayment | - | - | - | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | -20.11 Million | -210 Thousand | - | -118 Thousand |
| Common Stock Issuance | 952 Thousand | -2.34 Million | 671.68 Million | -292 Thousand | - | - |
| Other Financing Activities | - | - | -20.11 Million | -1.4 Million | - | - |
| Accounts receivables | -3.15 Million | -5.47 Million | -8.42 Million | 2.38 Million | - | 2.03 Million |
| Accounts payables | 5.89 Million | 858 Thousand | 4.97 Million | -4.26 Million | - | -2 Million |
| Inventory | 4.69 Million | -70 Thousand | -5.9 Million | -5.56 Million | - | 916 Thousand |
| Other working capital | 19.97 Million | -2.64 Million | 7.12 Million | -2.23 Million | - | -7.14 Million |
| Cash at beginning of period | 421.07 Million | 696.07 Million | 45.09 Million | 76.08 Million | 93.68 Million | 107.59 Million |
| Cash at end of period | 126.11 Million | 421.07 Million | 696.07 Million | 45.09 Million | 93.68 Million | 93.68 Million |
| Capital Expenditure | -16.69 Million | 1.32 Million | -3.42 Million | -2.76 Million | - | -575 Thousand |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | -294.95 Million | -275 Million | 650.97 Million | -30.99 Million | - | -13.91 Million |
| Free Cash Flow | 46.81 Million | 31.13 Million | 228 Thousand | -15.47 Million | - | -23.53 Million |
XMTR
CBFV
NDGPF
SAITW
6324
603208